1-7 of 7 results for subject:Imports
Librarians' tools
- Search time
- 0.179 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:Imports
- We searched for
- subject_t:Imports OR subject_ses:91618
Type
House
Session
More
2006-07 (7)
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
USA (7)
Publisher
(2) what advice her Department received between 1977 and 1989 from the World Health Organisation on the safety of imported blood from the US; and if she will make a statement.
(2) what advice her Department received between 1977 and 1989 from the World Health Organisation on the safety of imported blood from the US; and if she will make a statement.
Asked by
Jenny Willott
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
26 April 2007
For answer on
30 April 2007
Answered on
15 May 2007
We are not aware of advice received from the World Health Organisation (WHO) on the safety of imported blood. The Department of Health and Social Security at the time supported the WHO policy that each country should be able to supply its own blood and blood products. Further information about the policy to be self sufficient in blood products is contained in the report, ““Self-Sufficiency in Blood Products in England and Wales””. A copy has been placed in the Library.In 1975 a WHO resolution made a number of recommendations in relation to blood safety (resolution 28.72).
Subjects
Blood; Imports; USA
Date
15 May 2007
Reference
135266; 460 c717W
House
House of Commons
(9) what volume and proportion of blood products given to haemophiliacs in (a) 1977, (b) 1978 and (c) 1979 were sourced from USA donors; and if she will make a statement.
(9) what volume and proportion of blood products given to haemophiliacs in (a) 1977, (b) 1978 and (c) 1979 were sourced from USA donors; and if she will make a statement.
Asked by
Jenny Willott
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
26 April 2007
For answer on
30 April 2007
Answered on
14 May 2007
During the 1970s and 1980s the Department did not purchase imported blood products. At the time, Blood Products Laboratory (BPL) made plasma products from plasma collected from British blood donors. From 1999 BPL has obtained plasma from the United States as a precautionary measure against vCJD transmission by United Kingdom plasma. All US plasma collection centres are highly regulated and conform to a strict code of practice.Clinicians have been able to directly procure blood products from other sources and data on their use is not collected centrally. However, the report ““Self Sufficiency in Blood Products in England and Wales”” contains information on the annual consumption of factor VIII in the UK (table two) for the years 1969-1987. In addition, further information on the consumption of both the BPL and commercial blood products is contained in two articles ““Treatment of Haemophilia in the United Kingdom 1981-1996””, by Rizza CR et al Haemophilia (2001) 7, 349-359; and ““Treatment of haemophilia in related disorders in Britain and Northern Ireland during 1976-80””, by Rizza CR et al British Medical Journal (286) 1983. Copies of these articles have been placed in the Library.
Subjects
Blood; Imports; Haemophilia; USA
Date
14 May 2007
Reference
135277; 460 c572-3W
House
House of Commons
(8) what volume of factor VIII blood product was imported from the US into the UK in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989; and if she will make a statement;
(8) what volume of factor VIII blood product was imported from the US into the UK in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989; and if she will make a statement;
Asked by
Jenny Willott
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
26 April 2007
For answer on
30 April 2007
Answered on
14 May 2007
During the 1970s and 1980s the Department did not purchase imported blood products. At the time, Blood Products Laboratory (BPL) made plasma products from plasma collected from British blood donors. From 1999 BPL has obtained plasma from the United States as a precautionary measure against vCJD transmission by United Kingdom plasma. All US plasma collection centres are highly regulated and conform to a strict code of practice.Clinicians have been able to directly procure blood products from other sources and data on their use is not collected centrally. However, the report ““Self Sufficiency in Blood Products in England and Wales”” contains information on the annual consumption of factor VIII in the UK (table two) for the years 1969-1987. In addition, further information on the consumption of both the BPL and commercial blood products is contained in two articles ““Treatment of Haemophilia in the United Kingdom 1981-1996””, by Rizza CR et al Haemophilia (2001) 7, 349-359; and ““Treatment of haemophilia in related disorders in Britain and Northern Ireland during 1976-80””, by Rizza CR et al British Medical Journal (286) 1983. Copies of these articles have been placed in the Library.
Subjects
Blood; Imports; USA
Date
14 May 2007
Reference
135267; 460 c572-3W;460 c573-4W
House
House of Commons
(2) what volume of factor VIII blood product was imported from the US into the UK in (a) 1977, (b) 1978 and (c) 1979; and if she will make a statement;
(2) what volume of factor VIII blood product was imported from the US into the UK in (a) 1977, (b) 1978 and (c) 1979; and if she will make a statement;
Asked by
Jenny Willott
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
25 April 2007
For answer on
27 April 2007
Answered on
14 May 2007
During the 1970s and 1980s the Department did not purchase imported blood products. At the time, Blood Products Laboratory (BPL) made plasma products from plasma collected from British blood donors. From 1999 BPL has obtained plasma from the United States as a precautionary measure against vCJD transmission by United Kingdom plasma. All US plasma collection centres are highly regulated and conform to a strict code of practice.Clinicians have been able to directly procure blood products from other sources and data on their use is not collected centrally. However, the report ““Self Sufficiency in Blood Products in England and Wales”” contains information on the annual consumption of factor VIII in the UK (table two) for the years 1969-1987. In addition, further information on the consumption of both the BPL and commercial blood products is contained in two articles ““Treatment of Haemophilia in the United Kingdom 1981-1996””, by Rizza CR et al Haemophilia (2001) 7, 349-359; and ““Treatment of haemophilia in related disorders in Britain and Northern Ireland during 1976-80””, by Rizza CR et al British Medical Journal (286) 1983. Copies of these articles have been placed in the Library.
Subjects
Blood; Imports; USA
Date
14 May 2007
Reference
134903; 460 c572-3W
House
House of Commons
To ask the Secretary of State for Health (1) how much her Department spent on imported blood products from the US in (a) 1977, (b) 1978 and (c) 1979; and if she will make a statement;
To ask the Secretary of State for Health (1) how much her Department spent on imported blood products from the US in (a) 1977, (b) 1978 and (c) 1979; and if she will make a statement;
Asked by
Jenny Willott
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
25 April 2007
For answer on
27 April 2007
Answered on
14 May 2007
During the 1970s and 1980s the Department did not purchase imported blood products. At the time, Blood Products Laboratory (BPL) made plasma products from plasma collected from British blood donors. From 1999 BPL has obtained plasma from the United States as a precautionary measure against vCJD transmission by United Kingdom plasma. All US plasma collection centres are highly regulated and conform to a strict code of practice.Clinicians have been able to directly procure blood products from other sources and data on their use is not collected centrally. However, the report ““Self Sufficiency in Blood Products in England and Wales”” contains information on the annual consumption of factor VIII in the UK (table two) for the years 1969-1987. In addition, further information on the consumption of both the BPL and commercial blood products is contained in two articles ““Treatment of Haemophilia in the United Kingdom 1981-1996””, by Rizza CR et al Haemophilia (2001) 7, 349-359; and ““Treatment of haemophilia in related disorders in Britain and Northern Ireland during 1976-80””, by Rizza CR et al British Medical Journal (286) 1983. Copies of these articles have been placed in the Library.
Subjects
Blood; Imports; USA
Date
14 May 2007
Reference
134902; 460 c572-3W
House
House of Commons
(5) how much and what proportion of blood products given to haemophiliacs in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989 was sourced from the US; and if she will make a statement;
(5) how much and what proportion of blood products given to haemophiliacs in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989 was sourced from the US; and if she will make a statement;
Asked by
Jenny Willott
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
25 April 2007
For answer on
27 April 2007
Answered on
14 May 2007
During the 1970s and 1980s the Department did not purchase imported blood products. At the time, Blood Products Laboratory (BPL) made plasma products from plasma collected from British blood donors. From 1999 BPL has obtained plasma from the United States as a precautionary measure against vCJD transmission by United Kingdom plasma. All US plasma collection centres are highly regulated and conform to a strict code of practice.Clinicians have been able to directly procure blood products from other sources and data on their use is not collected centrally. However, the report ““Self Sufficiency in Blood Products in England and Wales”” contains information on the annual consumption of factor VIII in the UK (table two) for the years 1969-1987. In addition, further information on the consumption of both the BPL and commercial blood products is contained in two articles ““Treatment of Haemophilia in the United Kingdom 1981-1996””, by Rizza CR et al Haemophilia (2001) 7, 349-359; and ““Treatment of haemophilia in related disorders in Britain and Northern Ireland during 1976-80””, by Rizza CR et al British Medical Journal (286) 1983. Copies of these articles have been placed in the Library.
Subjects
Blood; Imports; Haemophilia; USA; Blood transfusions
Date
14 May 2007
Reference
134909; 460 c572-3W
House
House of Commons
(7) how much her Department spent on imported blood products from the US in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989; and if she will make a statement;
(7) how much her Department spent on imported blood products from the US in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989; and if she will make a statement;
Asked by
Jenny Willott
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
25 April 2007
For answer on
27 April 2007
Answered on
14 May 2007
During the 1970s and 1980s the Department did not purchase imported blood products. At the time, Blood Products Laboratory (BPL) made plasma products from plasma collected from British blood donors. From 1999 BPL has obtained plasma from the United States as a precautionary measure against vCJD transmission by United Kingdom plasma. All US plasma collection centres are highly regulated and conform to a strict code of practice.Clinicians have been able to directly procure blood products from other sources and data on their use is not collected centrally. However, the report ““Self Sufficiency in Blood Products in England and Wales”” contains information on the annual consumption of factor VIII in the UK (table two) for the years 1969-1987. In addition, further information on the consumption of both the BPL and commercial blood products is contained in two articles ““Treatment of Haemophilia in the United Kingdom 1981-1996””, by Rizza CR et al Haemophilia (2001) 7, 349-359; and ““Treatment of haemophilia in related disorders in Britain and Northern Ireland during 1976-80””, by Rizza CR et al British Medical Journal (286) 1983. Copies of these articles have been placed in the Library.
Subjects
Blood; Imports; USA
Date
14 May 2007
Reference
134911; 460 c572-3W
House
House of Commons